Pfizer, Ranbaxy prevail in antitrust fight over Lipitor generics

Tracy Staton

and Laboratories persuaded a U.S. judge to toss out an lawsuit accusing them of conspiring to delay generic versions of the cholesterol-fighting blockbuster .

FiercePharma News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS